Dihydroergotamine Mesylate and Methylphenidate Extended-Release Tablets
Determining the interaction of Dihydroergotamine Mesylate and Methylphenidate Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: methylphenidate
Brand name: Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Jornay PM, Metadate CD, Metadate ER, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Ritalin SR, Daytrana, Methylin ER
Synonyms: Methylphenidate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine Mesylate-Methylphenidate Hydrochloride
- Dihydroergotamine Mesylate-Methylphenidate LA Capsules
- Dihydroergotamine Mesylate-Methylphenidate Oral Solution
- Dihydroergotamine Mesylate-Methylphenidate Oral, Transdermal
- Dihydroergotamine Mesylate-Methylphenidate Tablets
- Dihydroergotamine Mesylate-Methylphenidate transdermal
- Methylphenidate Extended-Release Tablets-Dihydroergotamine nasal
- Methylphenidate Extended-Release Tablets-Dihydroergotamine Nasal Spray
- Methylphenidate Extended-Release Tablets-Dilacor XR
- Methylphenidate Extended-Release Tablets-Dilantin
- Methylphenidate Extended-Release Tablets-Dilantin Infatabs
- Methylphenidate Extended-Release Tablets-Dilantin injection